|
GB1555654A
(en)
*
|
1977-06-25 |
1979-11-14 |
Exxon Research Engineering Co |
Agricultural burner apparatus
|
|
NO154918C
(no)
*
|
1977-08-27 |
1987-01-14 |
Bayer Ag |
Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
|
|
DE2834122A1
(de)
*
|
1978-08-03 |
1980-02-14 |
Bayer Ag |
Verfahren zur herstellung von 6-amino-6-desoxy-l-sorbose
|
|
DE2839309A1
(de)
*
|
1978-09-09 |
1980-03-27 |
Bayer Ag |
3,4,5-trihydroxypiperidin-derivate
|
|
DE2853573A1
(de)
*
|
1978-12-12 |
1980-07-03 |
Bayer Ag |
Herstellung von n-substituierten derivaten des l-desoxynojirimycins
|
|
DE3038901A1
(de)
*
|
1980-10-15 |
1982-05-06 |
Bayer Ag, 5090 Leverkusen |
Verfahren zur herstellung von n-substituierten derivaten des 1-desoxynojirimycins
|
|
DE3611841A1
(de)
*
|
1986-04-09 |
1987-10-15 |
Bayer Ag |
Verfahren zur herstellung von 1-desoxynojirimycin und dessen n-derivaten
|
|
US5103008A
(en)
*
|
1989-08-17 |
1992-04-07 |
Monsanto Company |
Compound, N-butyl-deoxynojirimycin-6-phosphate
|
|
US5043273A
(en)
*
|
1989-08-17 |
1991-08-27 |
Monsanto Company |
Phosphorylated glycosidase inhibitor prodrugs
|
|
US4994572A
(en)
*
|
1989-10-12 |
1991-02-19 |
Monsanto Company |
Synthesis of nojirimycin derivatives
|
|
US5030638A
(en)
*
|
1990-02-26 |
1991-07-09 |
G. D. Searle & Co. |
Method of antiviral enhancement
|
|
US5200523A
(en)
*
|
1990-10-10 |
1993-04-06 |
Monsanto Company |
Synthesis of nojirimycin derivatives
|
|
US5206251A
(en)
*
|
1992-04-01 |
1993-04-27 |
G. D. Searle & Co. |
2- and 3- amino and azido derivatives of 1,5-iminosugars
|
|
US5399567A
(en)
*
|
1993-05-13 |
1995-03-21 |
Monsanto Company |
Method of treating cholera
|
|
WO1995022975A1
(en)
*
|
1994-02-25 |
1995-08-31 |
G.D. Searle & Co. |
Use of 1-deoxynojirimycin and its derivatives for treating mammals infected with respiratory syncytial virus
|
|
AU761748B2
(en)
*
|
1997-12-11 |
2003-06-12 |
Chancellor, Masters And Scholars Of The University Of Oxford, The |
Inhibition of membrane-associated viral replication
|
|
US6689759B1
(en)
*
|
1998-02-12 |
2004-02-10 |
G. D. Searle & Co. |
Methods of Treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy
|
|
US6610703B1
(en)
*
|
1998-12-10 |
2003-08-26 |
G.D. Searle & Co. |
Method for treatment of glycolipid storage diseases
|
|
GB9828474D0
(en)
*
|
1998-12-24 |
1999-02-17 |
British Aerospace |
Surface topology inspection
|
|
ES2311921T3
(es)
*
|
1999-02-12 |
2009-02-16 |
United Therapeutics Corporation |
N-(8,8,8-trifluorooctil)1-5,-didesoxi-1,5-imino-d-glucitol para tratar infecciones por el virus de la hepatitis.
|
|
GB0100889D0
(en)
*
|
2001-01-12 |
2001-02-21 |
Oxford Glycosciences Uk Ltd |
Compounds
|
|
AU6050600A
(en)
*
|
1999-07-26 |
2001-02-13 |
G.D. Searle & Co. |
Use of long-chain n-alkyl derivates of deoxynojirimycin and a glucocerebrosidaseenzyme for the manufacture of medicament for the treatment of glycolipid storag e diseases
|
|
US7256005B2
(en)
*
|
1999-08-10 |
2007-08-14 |
The Chancellor, Masters And Scholars Of The University Of Oxford |
Methods for identifying iminosugar derivatives that inhibit HCV p7 ion channel activity
|
|
US6565487B1
(en)
*
|
2000-07-17 |
2003-05-20 |
Hai Pin Kuo |
Exerciser having a forward and rearward adjusting seat
|
|
CN102586205A
(zh)
*
|
2003-01-31 |
2012-07-18 |
纽约大学西奈山医学院 |
酶和酶的活性部位特异性陪伴分子的组合
|
|
US7446098B2
(en)
*
|
2003-02-18 |
2008-11-04 |
Mount Sinai School Of Medicine Of New York University |
Combination therapy for treating protein deficiencies
|
|
US20060211752A1
(en)
*
|
2004-03-16 |
2006-09-21 |
Kohn Leonard D |
Use of phenylmethimazoles, methimazole derivatives, and tautomeric cyclic thiones for the treatment of autoimmune/inflammatory diseases associated with toll-like receptor overexpression
|
|
US20050256168A1
(en)
*
|
2004-04-28 |
2005-11-17 |
Block Timothy M |
Compositions for oral administration for the treatment of interferon-responsive disorders
|
|
US7524829B2
(en)
*
|
2004-11-01 |
2009-04-28 |
Avi Biopharma, Inc. |
Antisense antiviral compounds and methods for treating a filovirus infection
|
|
GB0501352D0
(en)
*
|
2005-01-21 |
2005-03-02 |
Slingsby Jason H |
Use of glycosylation modulators in combination with membrane fusion inhibitors for treatment of infections caused by viruses bearing glycosylated envelope
|
|
EP1863527A2
(en)
*
|
2005-03-16 |
2007-12-12 |
University of Oxford |
Mannose immunogens for hiv-1
|
|
CN101355971A
(zh)
*
|
2005-05-17 |
2009-01-28 |
阿米库斯治疗学公司 |
使用1-去氧野尻霉素衍生物治疗庞皮病的方法
|
|
EP3782655A1
(en)
*
|
2005-05-17 |
2021-02-24 |
Amicus Therapeutics, Inc. |
A method for the treatment of pompe disease using 1-deoxynojirimycin and derivatives
|
|
AU2006272497B2
(en)
*
|
2005-07-27 |
2012-07-19 |
University Of Florida Research Foundation, Inc. |
Small compounds that correct protein misfolding and uses thereof
|
|
NZ565954A
(en)
*
|
2005-07-27 |
2012-03-30 |
Univ Florida |
Use of heat shock inducing compound and an agent that increases stem cell mobilization int he manufacture of a medicament to treat ocular disease
|
|
US20070244184A1
(en)
*
|
2006-01-09 |
2007-10-18 |
Simon Fraser University |
Glycosidase inhibitors and methods of synthesizing same
|
|
ATE479696T1
(de)
*
|
2006-04-24 |
2010-09-15 |
Amc Amsterdam |
Verbessertes verfahren zur behandlung von cystischer fibrose
|
|
CA2652958C
(en)
*
|
2006-05-24 |
2015-11-17 |
United Therapeutics Corporation |
Deoxynojirimycin and d-arabinitol analogs and methods of using
|
|
KR20090040906A
(ko)
*
|
2006-08-02 |
2009-04-27 |
유나이티드 세러퓨틱스 코오포레이션 |
바이러스 감염의 리포솜 치료
|
|
CA2666814A1
(en)
*
|
2006-08-21 |
2008-05-29 |
United Therapeutics Corporation |
Combination therapy for treatment of viral infections
|
|
WO2009118658A2
(en)
*
|
2008-03-26 |
2009-10-01 |
University Of Oxford |
Endoplasmic reticulum targeting liposomes
|
|
US9040488B2
(en)
|
2008-09-02 |
2015-05-26 |
Baruch S. Blumberg Institute |
Imino sugar derivatives demonstrate potent antiviral activity and reduced toxicity
|